Potential Prognostic Markers for Relapsed/Refractory vs. Responsive Acute Myeloid Leukemia

SIMPLE SUMMARY: Acute myeloid leukemia (AML) is the most common blood cancer in the elderly, which progresses rapidly and is often fatal. The prognosis for AML remains poor in most older patients: only about 15% of patients over 60 years of age can recover. Our aim is to determine new potential AML...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitkevičienė, Aida, Skliutė, Giedrė, Žučenka, Andrius, Borutinskaitė, Veronika, Navakauskienė, Rūta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179343/
https://www.ncbi.nlm.nih.gov/pubmed/35681732
http://dx.doi.org/10.3390/cancers14112752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179343/
https://www.ncbi.nlm.nih.gov/pubmed/35681732
http://dx.doi.org/10.3390/cancers14112752

Ejemplares similares